Phosphorous magnetic resonance spectroscopy-based skeletal muscle bioenergetic studies in subclinical hypothyroidism

Journal of Endocrinological Investigation

Volumn 35, Issue 2, 2012, Pages 129-134

  Rana, P ^a   Sripathy, G ^a,b   Varshney, A ^a   Kumar, P ^a   Memita Devi, M ^a   Marwaha, R K ^a   Tripathi, R P ^a   Khushu, S ^a  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b Government of India   (India)

Author keywords

Muscle metabolism; Phosphorous MR spectroscopy; Subclinical hypothyroidism

Indexed keywords

CREATINE PHOSPHATE; PHOSPHATE;

ADULT; AEROBIC METABOLISM; ARTICLE; BIOENERGY; CLINICAL ARTICLE; FEMALE; GASTROCNEMIUS MUSCLE; HUMAN; MALE; MUSCLE EXERCISE; MUSCLE FUNCTION; MUSCLE METABOLISM; PATIENT MONITORING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; SKELETAL MUSCLE; SUBCLINICAL HYPOTHYROIDISM;

ADULT; ASYMPTOMATIC DISEASES; ENERGY METABOLISM; EXERCISE; FEMALE; HUMANS; HYPOTHYROIDISM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PHOSPHOCREATINE; PHOSPHORUS; RECOVERY OF FUNCTION; REST; YOUNG ADULT;

EID: 84862902653     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7676     Document Type: Article

References (34)

1. th ed. Philadelphia: Lippincott-Raven Press, 1996.
2. Kabadi UM. 'Subclinical hypothyroidism'. Natural course of the syndrome during a prolonged follow-up study. Arch Intern Med 1993, 153: 957-61.
3. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004, 291: 228-38.
4. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab 2005, 90: 581-5.
5. Cakir M, Samanci N, Balci N, Balci K. Muskuloskeletal manifestations in patients with thyroid disease. Clin Endocrinol (Oxf) 2003, 59: 162-7.
6. Gonçalves A, Resende ES, Fernandes ML, da Costa AM. Effect of thyroid hormones on cardiovascular and muscle systems and on exercise tolerance: A brief review. Arq Bras Cardiol 2006, 87: e42-4.
7. Kaminsky P, Robin-Lherbier B, Brunotte F, et al. Energetic metabolism in hypothyroid skeletal muscle, as studied by phosphorous magnetic resonance spectroscopy. J Clin Endocrinol Metabol 1992, 74: 124-9.
8. Taylor DJ, Rajagopalan B, Radda GK. Cellular energetics in hypothyroid muscle. Eur J Clin Invest 1992, 22: 358-65.
9. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008, 29: 76-131.
10. Monzani F, Caraccio N, Siciliano G, Manca L, Murri L, Ferrannini E. Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J Clin Endocrinol Metab 1997, 82: 3315-8.
11. Monzani F, Caraccio N, Del Guerra P, Casolaro A, Ferrannini E. Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy. Clin Endocrinol 1999, 51: 237-42.
12. Caraccio N, Natali A, Sironi A, et al. Muscle metabolism and exercise tolerance in subclinical hypothyroidism: A controlled trial of Levothyroxine. J Clin Endocrinol 2005, 90: 4057-62.
13. Chance B, Eleff S, Leigh JS, Sokolov D, Sapega A. Mitochondrial regulation of phosphocreatine /inorganic phosphate ratios in exercising human muscle: A gated 31-P NMR study. Proc Natl Acad Sci U S A 1981, 78: 6714-8.
14. Argov Z, Löfberg M, Arnold DL. Insight into muscle diseases gained by phosphorous magnetic resonance spectroscopy. Muscle Nerve 2000, 23: 1316-34.
15. Matthews PM, Allaire C, Shoubridge EA, Karpati G, Carpenter S, Arnold DL. In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease. Neurology 1991, 41: 114-20.
16. Isbell DC, Berr SS, Toledano AY, et al. Delayed calf muscle phosphocreatine recovery after exercise identifies peripheral arterial disease. J. Am Coll cardiol 2006, 47: 2289-95.
17. Jaworowski A, Porter MM, Holmbäck AM, Downham D, Lexell J. Enzyme activities in the tibialis anterior muscle of young moderately active men and women: relationship with body composition, muscle cross-sectional area and fibre type composition. Acta Physiol Scand 2002, 176: 215-25.
18. Mattei JP, Bendahan D, Roussel M, Lefur Y, Cozzone PJ. Gender modulates the energy cost of muscle contraction in untrained healthy subjects: A 31P magnetic resonance spectroscopy analysis. FEBS Lett 1999, 450: 173-7.
19. Rana P, Varshney A, Devi MM, Kumar P, Khushu S. Non invasive assessment of oxidative capacity in young Indian men and women: A 31P MR spectroscopy study. Ind J Biochem Biophy 2008, 45: 263-8.
20. Kemp GJ, Meyerspeer M, Moser E. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review. NMR Biomed 2007, 20: 555-65.
21. Meyer RA. A linear model of muscle respiration explains monoexponential phosphocreatine changes. Am J Physiol 1988, 254: C548-53.
22. Argov Z, Renshaw PF, Boden B, Winokur A, Bank WJ. Effect of thyroid hormones on skeletal muscle bioenergetics: In vivo phosphorous 31 magnetic resonance spectroscopy study of humans and rats. J Clin Invest 1988, 81: 1695-701.
23. Khushu S, Rana P, Sekhri T, Sripathy G, Tripathi RP. Bio-energetic impairment in human calf muscle in thyroid disorders: A 31P NMR spectroscopy study. Magn Reson Imaging 2010, 28: 683-9.
24. Jubrias SA, Bennett RM, Klug GA. Increased incidence of resonance in the phosdphodiester region of 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients. Arth Rheum 1994, 37: 801-7.
25. Khaleeli AA, Gohil K, McPhail G, Round JM, Edwards RH. Muscle morphology and metabolism in hypothyroid myopathy: effect of treatment. J Clin Pathol 1983, 36: 519-26.
26. Bahi L, Garnier A, Fortin D, et al. Differential effects of thyroid hormones on energy metabolism of rat slow and fast-twitch muscles. J Cell Physiol 2005, 203: 589-98.
27. Dunn ME, Hennessey JV, Cosmas AC, Lamont LS, Manfredi TG. Ultrastructural evidence of skeletal muscle mitochondrial dysfunction in patients with subclinical hypothyroidism. Thyroid Sci 2009, 4: CR1-8.
28. Khushu S, Kumaran SS, Sankar R, et al. 31P magnetic resonance spectroscopy of healthy human calf muscle. Curr Sci 2001, 81: 1350-3.
29. Bose S, French S, Evans FJ, Joubert F, Balaban RS. Metabolic network control of oxidative phosphorylation: multiple roles of inorganic phosphate. J Biol Chem 2003, 278: 39155-65.
30. Gyulai L, Roth Z, Leigh Jr JS, Chance B. Bioenergetic studies of mitochondrial oxidative phosphorylation using 31P NMR. J Biol Chem 1985, 260: 3947-54.
31. Paganini AT, Foley JM, Meyer RA. Linear dependence of muscle phosphocreatine kinetics on oxidative capacity. Am J Physiol 1997, 272: C501-10.
32. Sterling K, Lazarus JH, Milch PO, Sakurada T, Brenner MA. Mitochondrial thyroid hormone receptor: localization and physiological significance. Science 1978, 201: 1126-9.
33. Wrutniak-Cabello C, Casas F, Cabello G. Thyroid hormone action in mitochondria. J Mol Endocrinol 2001, 26: 67-77.
34. Kent-Braun JA, Ng AV. Skeletal muscle oxidative capacity in young and older women and men. J Appl Physiol 2000, 89: 1072-8.